Dr. Silvana Papagerakis is an established clinician-scientist in the field of oral, head and neck cancer with over 20 years of research success in basic, translational and clinical research within research intensive academic health settings. Her expertise encompasses qualitative and quantitative patient oriented research; cancer epidemiology, prevention and control; clinical trials; outcomes prediction; anti-cancer drug reformulation and personalized therapeutics; precision molecular medicine; chemical and viral (e.g. Human Papillomavirus) carcinogenesis; epigenetics; tumor heterogeneity, microenvironment and metabolism; in vivo an in vitro experimental models. She has collaborative inter-disciplinary projects in circadian disruption, dentistry and autoimmune diseases with a special interest in the cross talk between oral and systemic heath. Her work has received national and international research recognitions. Dr. Papagerakis relocated from the University of Michigan Ann Arbor, USA, where she maintains an adjunct faculty position in the Department of Otolaryngology.